MT Newswires•14 days agoMarket Chatter: ZIM's Sale to Hapag-Lloyd, FIMI Unlikely to Win Israeli Regulatory Approval
Business Wire•26 days agoCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 20264507.T0.09%